Literature DB >> 28645322

Erratum to: Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in mid-Norway: a prospective observational study.

Arne Mehl1,2,3, Bjørn Olav Åsvold4,5,6, Angela Kümmel7, Stian Lydersen8, Julie Paulsen9,4,10, Ingvild Haugan11, Erik Solligård4,12,13, Jan Kristian Damås4,10,14, Stig Harthug15,16, Tom-Harald Edna17,18.   

Abstract

Entities:  

Year:  2017        PMID: 28645322      PMCID: PMC5481901          DOI: 10.1186/s12879-017-2545-z

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


× No keyword cloud information.

Erratum

After publication of the original article [1] the authors found the following errors had occurred: The y-axis of Fig. 3 has been incorrectly titled ‘Percent’. The correct title is ‘Number of episodes’. (Fig. 3).
Fig. 3

Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility

The legend of Fig. 3 did not contain correct information on the figure. Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility The legend on Fig. 3 was originally labelled: Microbes non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. (Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail) ANS, acquired non-susceptibility; INS, inherent non-susceptibility However, this has been corrected to: Number of BSI episodes with microbe(s) non-susceptible to penicillin-gentamicin-metronidazole (PGM) through three time periods. Additional file 1: Table S5 shows the PGM non-susceptible microbes in detail. The percentages of episodes with microbe(s) non-susceptible to PGM were 1.9%, 3.0%, and 5.2% in 2002–2005, 2006–2009, and 2010–2013, respectively. ANS, acquired non-susceptibility; INS, inherent non-susceptibility (Fig. 3) A corrected version of the figure is included in this Erratum:
  1 in total

1.  Trends in antimicrobial resistance and empiric antibiotic therapy of bloodstream infections at a general hospital in Mid-Norway: a prospective observational study.

Authors:  Arne Mehl; Bjørn Olav Åsvold; Angela Kümmel; Stian Lydersen; Julie Paulsen; Ingvild Haugan; Erik Solligård; Jan Kristian Damås; Stig Harthug; Tom-Harald Edna
Journal:  BMC Infect Dis       Date:  2017-02-02       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.